3/2/2022 | IGLM | Bristol-Myers details early tender amounts and pricing, tweaks offer
|
3/2/2022 | IGLM | Bristol-Myers Squibb details early tender amounts, tweaks offer
|
2/15/2022 | IGLM | Bristol-Myers Squibb to buy notes from 22 series for up to $4 billion
|
2/22/2021 | IGLM | Bristol-Myers, Celgene to redeem 4% notes, 3.25% notes due 2023
|
2/19/2021 | IGLM | Bristol-Myers Squibb announces pricing on tender offers for 20 series
|
2/19/2021 | IGLM | Bristol-Myers Squibb gives early results of tender offers for 20 series
|
2/4/2021 | BWIGLM | Bristol-Myers starts leverage reduction goal with $4 billion tender
|
2/4/2021 | IGLM | Bristol-Myers Squibb kicks off $4 billion tender offers for 20 series
|
12/6/2019 | BKIG | Moody’s lifts Celgene debt
|
11/21/2019 | BKIG | S&P boosts Celgene, off watch
|
11/21/2019 | IGLM | Bristol-Myers announces results of exchange offers for Celgene notes
|
11/15/2019 | IGLM | Bristol-Myers Squibb extends exchange offers for Celgene notes
|
11/12/2019 | IGLM | Bristol-Myers Squibb extends exchange offers for Celgene notes
|
11/7/2019 | IGLM | Bristol-Myers Squibb extends exchange offers for Celgene notes
|
11/5/2019 | IGLM | Bristol-Myers Squibb again extends exchange offers for Celgene notes
|
11/1/2019 | IGLM | Bristol-Myers Squibb again extends exchange offers for Celgene notes
|
10/30/2019 | IGLM | Bristol-Myers Squibb extends exchange offers for Celgene notes
|
10/18/2019 | IGLM | Bristol-Myers Squibb extends exchange offers for Celgene notes
|
10/8/2019 | IGLM | Bristol-Myers Squibb extends exchange offers for Celgene notes
|
9/23/2019 | IGLM | Bristol-Myers Squibb again extends exchange offers for Celgene notes
|
6/28/2019 | IGLM | Bristol-Myers extends exchange offers for Celgene notes
|
5/24/2019 | IGLM | Bristol-Myers extends exchange offers for Celgene notes
|
5/2/2019 | IGLM | Bristol-Myers gives early results of offers for Celgene notes
|
4/25/2019 | IG | Market Commentary: Omers taps primary; Bristol-Myers Squibb deal on horizon; corporate inflows jump; Walmart soft
|
4/17/2019 | IGLM | Bristol-Myers Squibb launches exchange offer for 19 Celgene notes
|
1/4/2019 | BKIG | S&P puts Celgene on positive watch
|
2/8/2018 | IG | Market Commentary: Celgene prices $4.5 billion; Senior Housing sells notes; high-grade credit spreads soften
|
2/8/2018 | IG | New Issue: Celgene prices $4.5 billion of senior notes in four tranches
|
2/8/2018 | BKIG | Moody’s rates Celgene notes Baa2
|
2/8/2018 | BKIG | S&P rates Celgene notes BBB+
|
2/8/2018 | IG | Market Commentary: Morning Commentary: Celgene, Senior Housing Properties Trust on tap; spreads weaken amid sell-off
|
2/8/2018 | IG | Celgene to sell fixed-rate notes due 2021, 2023, 2028, 2048
|
1/22/2018 | BKIG | S&P affirms Celgene
|
1/22/2018 | BWIG | Celgene plans new debt financing to fund $9 billion Juno acquisition
|
1/22/2018 | BKIG | Moody’s affirms Celgene
|
11/17/2017 | IG | Market Commentary: Morning Commentary: Boston Properties, Southern Co. offer notes; Anthem, Celgene better
|
10/31/2017 | IG | Market Commentary: Lloyds sells $4 billion notes; Celgene, GATX, Philip Morris, Constellation, Amgen price
|
10/31/2017 | IG | New Issue: Celgene prices $3 billion three-tranche offering of senior notes
|
10/31/2017 | BKIG | S&P rates Celgene notes BBB+
|
10/31/2017 | BKIG | Moody’s gives Baa2 to Celgene notes
|
10/31/2017 | IG | Market Commentary: Morning Commentary: Lloyds, Celgene, GATX, Philip Morris, Constellation, Amgen bonds on tap
|
10/31/2017 | IG | Celgene to sell three-part fixed-rate notes due 2023, 2027, 2047
|
10/31/2017 | IGLM | Celgene to call $1 billion 2.125% notes, $400 million 2.3% notes
|
8/1/2017 | IG | Market Commentary: Comcast, Verizon, Kimco Realty, Ryder, KfW price; Nordic Investment Bank markets notes
|
8/1/2017 | IG | New Issue: Celgene prices $500 million of 2.25% four-year notes at 83 bps over Treasuries
|
8/1/2017 | BKIG | S&P gives BBB+ to Celgene notes
|
8/1/2017 | BKIG | Moody’s rates Celgene notes Baa2
|
8/1/2017 | IG | Market Commentary: Morning Commentary: Verizon, Kimco Realty, Ryder, KfW market bonds; AT&T notes improve
|
8/1/2017 | IG | Celgene plans to offer four-year fixed-rate notes via Morgan Stanley
|
8/24/2015 | IG | Market Commentary: Morning Commentary: Credit spreads widen; Lloyds Bank paper improves; Celgene unchanged
|
8/10/2015 | IG | Market Commentary: Morning Commentary: Credit spreads firm; Celgene wrapped around issuance; Morgan Stanley soft
|
8/5/2015 | IG | Market Commentary: Morning Commentary: HSBC paper unchanged; Celgene notes tight in secondary trade; CDX flat
|
8/3/2015 | IG | Market Commentary: Celgene does $8 billion deal for Receptos acquisition; bank, financial paper tighten
|
8/3/2015 | IG | New Issue: Celgene prices $8 billion five-part senior notes offering for Receptos acquisition
|
8/3/2015 | BKIG | S&P rates Celgene notes BBB+
|
8/3/2015 | BKIG | Moody’s cuts Celegene, rates notes Baa2
|
8/3/2015 | IG | Celgene preps five-part notes offering for Receptos acquisition; pricing Monday
|
7/17/2015 | IG | Market Commentary: Primary wraps $49 billion week; pace to continue next week; energy, oil bonds mostly unchanged
|
7/17/2015 | IG | Celgene plans $8 billion senior notes sale for acquisition, general corporate purposes
|
7/15/2015 | BKIG | Celgene gets commitment for $5 billion bridge loan to finance merger
|
7/15/2015 | BKIG | S&P lowers Celgene to stable
|
7/15/2015 | BKIG | Moody’s could drop Celgene
|
4/21/2015 | BKIG | Moody's upgrades Celgene
|
6/12/2014 | BKIG | S&P lifts Celgene to positive
|
5/8/2014 | IG | Market Commentary: Hasbro, Oncor price; Province of Ontario on deck; Celgene mixed; National Retail better
|
5/8/2014 | IG | Market Commentary: Midday Commentary: Investment-grade bond spreads unchanged; Celgene firms; Apple flat
|
5/6/2014 | BKIG | Moody's gives Celgene notes Baa2
|
5/6/2014 | IG | Celgene selling notes in three parts Tuesday via four bookrunners
|
5/6/2014 | IG | New Issue: Celgene prices $2.5 billion of notes in tranches due 2019, 2024, 2044
|
5/6/2014 | IG | Market Commentary: Packed primary sees Celgene, JPMorgan price; Xerox upsizes; DirecTV, AT&T better
|
5/6/2014 | BKIG | S&P assigns Celgene notes BBB+
|
8/2/2013 | IG | Market Commentary: BNY sells floaters during quiet session to end week; Celgene notes firm; Time Warner rallies
|
8/1/2013 | IG | Celgene selling notes in three parts Thursday via four bookrunners
|
8/1/2013 | IG | Celgene selling senior notes Thursday via four bookrunners
|
8/1/2013 | IG | New Issue: Celgene prices $1.5 billion of senior notes in three tranches
|
8/1/2013 | IG | Market Commentary: Celgene, Ford, United Airlines sales bring primary back to life; financials, new issues firm
|
8/1/2013 | BKIG | S&P rates Celgene notes BBB+
|
8/1/2013 | BKIG | Moody's rates Celgene notes Baa2
|
6/12/2013 | BKIG | Moody's: Celgene view to positive
|
8/7/2012 | IG | New Issue: Celgene gives terms of $1.5 billion sale of senior notes in five-, 10-year tranches
|
8/6/2012 | IG | Market Commentary: Altria Group, Celgene, Westpac, Enterprise Products among bounty of deals; new bonds firm
|
8/6/2012 | IG | New Issue: Celgene sells $1.5 billion of senior notes in five-, 10-year tranches
|
8/6/2012 | IG | S&P rates Celgene notes BBB+
|
8/6/2012 | IG | Moody's: Celgene notes Baa2
|
9/16/2011 | IG | Celgene on track for earnings through 2015, CFO tells conference
|
9/7/2011 | IG | S&P rates Celgene paper A-2
|
9/7/2011 | IG | Moody's rates Celgene paper Prime-2
|
10/5/2010 | IG | Market Commentary: Rabobank, Entergy Arkansas, Tri-State sell bonds; Heico plans deal; CBS, Celgene paper firms
|
10/4/2010 | IG | Celgene files automatic shelf registration covering debt securities
|
10/4/2010 | IG | New Issue: Celgene sells upsized $1.25 billion of five-, 10-, 30-year notes
|
10/4/2010 | IG | S&P rates Celgene BBB+, notes BBB-
|
10/4/2010 | IG | Market Commentary: CBS, UIL, Celgene, Public Storage price high-grade deals; Boston Properties debt flat on deal
|